1. Home
  2. TIVC vs QNRX Comparison

TIVC vs QNRX Comparison

Compare TIVC & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIVC
  • QNRX
  • Stock Information
  • Founded
  • TIVC 2016
  • QNRX 2018
  • Country
  • TIVC United States
  • QNRX United States
  • Employees
  • TIVC N/A
  • QNRX N/A
  • Industry
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • QNRX Medical/Dental Instruments
  • Sector
  • TIVC Health Care
  • QNRX Health Care
  • Exchange
  • TIVC Nasdaq
  • QNRX Nasdaq
  • Market Cap
  • TIVC 1.8M
  • QNRX 2.1M
  • IPO Year
  • TIVC 2021
  • QNRX N/A
  • Fundamental
  • Price
  • TIVC $0.29
  • QNRX $0.62
  • Analyst Decision
  • TIVC
  • QNRX Strong Buy
  • Analyst Count
  • TIVC 0
  • QNRX 1
  • Target Price
  • TIVC N/A
  • QNRX $4.00
  • AVG Volume (30 Days)
  • TIVC 16.2M
  • QNRX 486.4K
  • Earning Date
  • TIVC 11-14-2024
  • QNRX 11-07-2024
  • Dividend Yield
  • TIVC N/A
  • QNRX N/A
  • EPS Growth
  • TIVC N/A
  • QNRX N/A
  • EPS
  • TIVC N/A
  • QNRX N/A
  • Revenue
  • TIVC $957,000.00
  • QNRX N/A
  • Revenue This Year
  • TIVC $324.15
  • QNRX N/A
  • Revenue Next Year
  • TIVC N/A
  • QNRX N/A
  • P/E Ratio
  • TIVC N/A
  • QNRX N/A
  • Revenue Growth
  • TIVC N/A
  • QNRX N/A
  • 52 Week Low
  • TIVC $0.22
  • QNRX $0.48
  • 52 Week High
  • TIVC $3.21
  • QNRX $6.18
  • Technical
  • Relative Strength Index (RSI)
  • TIVC 47.33
  • QNRX 43.57
  • Support Level
  • TIVC $0.24
  • QNRX $0.60
  • Resistance Level
  • TIVC $0.45
  • QNRX $0.77
  • Average True Range (ATR)
  • TIVC 0.06
  • QNRX 0.07
  • MACD
  • TIVC 0.00
  • QNRX -0.02
  • Stochastic Oscillator
  • TIVC 12.12
  • QNRX 12.98

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

Share on Social Networks: